Zenas BioPharma, Inc. Common Stock Earnings

The next earnings date for Zenas BioPharma, Inc. Common Stock is November 11, 2025.

They are scheduled to announce earnings before the market opens that day.

Analyst Estimates of Zenas BioPharma, Inc. Common Stock Earnings

Report DateEstimated Earnings Per Share
11/11/2025$0.39

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Zenas BioPharma, Inc. Common Stock Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
11/12/2024---$-0.92---

More About Zenas BioPharma, Inc. Common Stock

Country
USA
Full Time Employees
130

Zenas BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies. Its lead product candidate is obexelimab, a bifunctional monoclonal antibody designed to bind CD19 and Fc"RIIb for the treatment of various I&I diseases and various indications, including immunoglobulin G4-related disease, multiple sclerosis, and systemic lupus erythematosus. The company also develops ZB002, an anti-TNFa monoclonal antibody; ZB004, a cytotoxic T-lymphocyte-associated antigen 4-immunoglobulin fusion; and ZB001, an anti-IGF-1R monoclonal antibody. The company was formerly known as Zenas BioPharma (Cayman) Limited and changed its name to Zenas BioPharma, Inc. in August 2023. The company was incorporated in 2019 and is headquartered in Waltham, Massachusetts.

Zenas BioPharma, Inc. Common Stock Earnings” Can Refer to the Zenas BioPharma, Inc. Common Stock Earnings Date

Some people say “Zenas BioPharma, Inc. Common Stock earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Zenas BioPharma, Inc. Common Stock position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Zenas BioPharma, Inc. Common Stock Stock on the Earnings Date

If you own Zenas BioPharma, Inc. Common Stock stock (ZBIO) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Zenas BioPharma, Inc. Common Stock might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Zenas BioPharma, Inc. Common Stock shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Zenas BioPharma, Inc. Common Stock Earnings

You can contact us any time if you would like to ask questions about Zenas BioPharma, Inc. Common Stock earnings or anything else related to the stock market.